SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy platform for tissue-selective delivery, today announced the appointment of J.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback